Nasdaq

A newly published multicentre RCT demonstrates Smith+Nephew PICO single use NPWT as superior to traditional NPWT in reducing wound area, depth and volume in DFUs and VLUs

LONDON--(BUSINESS WIRE)-- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is excited to announce the publication of results from a new randomised controlled trial (RCT) ...
Nasdaq

Smith+Nephew announces US launch of PICO™ 14 Single Use Negative Pressure Wound Therapy System for use on high risk surgical patients

LONDON, March 3, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the US launch of the new PICO 14 Single Use Negative Pressure Wound ...
Reuters

Smith+Nephew Announces Us Launch Of PICO 14 Single Use Negative Pressure Wound Therapy System For Use On High Risk Surgical Patients

* SMITH+NEPHEW ANNOUNCES US LAUNCH OF PICO 14 SINGLE USE NEGATIVE PRESSURE WOUND THERAPY SYSTEM FOR USE ON HIGH RISK SURGICAL PATIENTS Source text for Eikon: Further company coverage: ...